As therapeutic isotope demand accelerates alongside clinical progression to later stage trials, many companies are confronting supply fragility. This workshop gathers an intimate group of senior supply chain, manufacturing, and CMC professionals to map real supply dependencies, stress-test their current supplier strategies, and leave with ideas to build an actionable resilience framework. Moving from peer input to structured exercises, this session addresses the realities of isotope scarcity today, and how teams can build smarter workflows before the next bottleneck hits.

Join this workshop to:

• Evaluate the supply maturity landscape for Lu-177, Ac-225, At-211, Pb-212, and emerging isotopes including Tb-161, and benchmark where your program sits against current production realities
• Discuss strategies for diversifying supply across reactor-based, cyclotron-based, and linear accelerator pathways, and assess the practical trade-offs of each for your pipeline stage
• Put on a ‘future-thinking’ lens to protect supply chains over the next 5-10 years